PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-11820745-B2 United States of America 21 Nov 2023
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-11390596-B2 United States of America 19 Jul 2022
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-10696644-B2 United States of America 30 Jun 2020
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-10323011-B2 United States of America 18 Jun 2019